These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29474707)

  • 1. Immune Relevant Models for Ocular Inflammatory Diseases.
    Gilger BC
    ILAR J; 2018 Dec; 59(3):352-362. PubMed ID: 29474707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dry eye disease and uveitis: A closer look at immune mechanisms in animal models of two ocular autoimmune diseases.
    Bose T; Diedrichs-Möhring M; Wildner G
    Autoimmun Rev; 2016 Dec; 15(12):1181-1192. PubMed ID: 27639836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intraocular inflammation and homeostasis of the eye].
    Mochizuki M
    Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):344-77; discussion 378. PubMed ID: 19348183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing advanced therapeutics through the study of naturally occurring immune-mediated ocular disease in domestic animals.
    Gilger BC
    Am J Vet Res; 2022 Oct; 83(11):. PubMed ID: 36201404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases.
    Fabiani C; Sota J; Tosi GM; Franceschini R; Frediani B; Galeazzi M; Rigante D; Cantarini L
    Clin Rheumatol; 2017 Oct; 36(10):2307-2318. PubMed ID: 28032234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental models of autoimmune inflammatory ocular diseases.
    Gasparin F; Takahashi BS; Scolari MR; Gasparin F; Pedral LS; Damico FM
    Arq Bras Oftalmol; 2012; 75(2):143-7. PubMed ID: 22760810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral and cellular immune reactions against retinal antigens in clinical disease.
    Kijlstra A; Hoekzema R; vd Lelij A; Doekes G; Rothova A
    Curr Eye Res; 1990; 9 Suppl():85-9. PubMed ID: 2200648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Patents and Emerging Therapeutics on Ocular Inflammation and Allergy.
    Agrahari V; Aulgur Z; Thukral S; Dhall N; Conley R; Mitra AK
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(2):92-106. PubMed ID: 28901856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenetics of ocular inflammatory disease.
    Levinson RD
    Tissue Antigens; 2007 Feb; 69(2):105-12. PubMed ID: 17257311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approach to Immune-mediated Ocular Diseases.
    Knickelbein KE; Lassaline ME
    Vet Clin North Am Equine Pract; 2024 Aug; 40(2):275-286. PubMed ID: 38806348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple etiologies of equine recurrent uveitis--A natural model for human autoimmune uveitis: A brief review.
    Witkowski L; Cywinska A; Paschalis-Trela K; Crisman M; Kita J
    Comp Immunol Microbiol Infect Dis; 2016 Feb; 44():14-20. PubMed ID: 26851589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologically mediated ocular disease in the horse.
    Hines MT
    Vet Clin North Am Large Anim Pract; 1984 Nov; 6(3):501-12. PubMed ID: 6393544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular immune privilege in the year 2010: ocular immune privilege and uveitis.
    Taylor AW; Kaplan HJ
    Ocul Immunol Inflamm; 2010 Dec; 18(6):488-92. PubMed ID: 21091058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular Involvement in Systemic Autoimmune Diseases.
    Generali E; Cantarini L; Selmi C
    Clin Rev Allergy Immunol; 2015 Dec; 49(3):263-70. PubMed ID: 26494481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular immunosuppressive microenvironment and novel drug delivery for control of uveitis.
    Teabagy S; Wood E; Bilsbury E; Doherty S; Janardhana P; Lee DJ
    Adv Drug Deliv Rev; 2023 Jul; 198():114869. PubMed ID: 37172782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management.
    Foster CS; Kothari S; Anesi SD; Vitale AT; Chu D; Metzinger JL; Cerón O
    Surv Ophthalmol; 2016; 61(1):1-17. PubMed ID: 26164736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation.
    Ratay ML; Bellotti E; Gottardi R; Little SR
    Adv Healthc Mater; 2017 Dec; 6(23):. PubMed ID: 29034584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunology in clinical practice. XIII. Immune diseases of the eye].
    Ooijman FM; van der Lelij A
    Ned Tijdschr Geneeskd; 1998 Feb; 142(9):443-8. PubMed ID: 9562756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases.
    Miserocchi E; Pontikaki I; Modorati G; Gattinara M; Meroni PL; Gerloni V
    Autoimmun Rev; 2011 Nov; 11(1):35-9. PubMed ID: 21763790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunology of chorioretinal disorders.
    Corwin JM; Weiter JJ
    Surv Ophthalmol; 1981; 25(5):287-305. PubMed ID: 6111850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.